+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Personalized Medicine In Oncology"

From
Denmark Pharmaceutical Market - Drug Development & Forecast 2026-2034 - Product Thumbnail Image

Denmark Pharmaceutical Market - Drug Development & Forecast 2026-2034

  • Report
  • September 2026
  • 200 Pages
  • Denmark
From
From
Oncology Biomarkers: Global Markets - Product Thumbnail Image

Oncology Biomarkers: Global Markets

  • Report
  • June 2023
  • 186 Pages
  • Global
From
The Chinese Market for DNA Sequencing - Product Thumbnail Image

The Chinese Market for DNA Sequencing

  • Report
  • September 2025
  • 82 Pages
  • China
From
U.S. Bispecific Antibodies Market Forecast to 2033 - Product Thumbnail Image

U.S. Bispecific Antibodies Market Forecast to 2033

  • Report
  • October 2025
  • 100 Pages
  • United States
From
From
Loading Indicator

Personalized Medicine in Oncology is a field of medicine that uses genomic information to tailor treatments to individual patients. This approach is based on the idea that each patient's cancer is unique and requires a personalized approach to treatment. Genomics is used to identify the genetic mutations that are driving the cancer, and then treatments are tailored to target those mutations. This approach has the potential to improve outcomes and reduce side effects, as treatments are more targeted and tailored to the individual patient. Companies in the Personalized Medicine in Oncology market include Illumina, Thermo Fisher Scientific, QIAGEN, Agilent Technologies, and PerkinElmer. Show Less Read more